Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c

Inhibrx, Inc. (NASDAQ: INBX) reported Q2 EPS of ($2.34), $0.54 worse than the analyst estimate of ($1.80).

For earnings history and earnings-related data on Inhibrx, Inc. (INBX) click here.

You May Also Be Interested In

• loanDepot receives NYSE non-compliance notice over stock price
• Sigma Lithium resumes full operations after signing TAC agreement
• OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises